Table 3 |
|||
|
Genotype frequency |
|||
|
ESR Xba I |
CONTROL |
DDH |
PPA |
|
|
|||
|
XX |
33(37.9%) |
24(55.8%) |
6(30%) |
|
Xx |
45(51.7%) |
18(41.9%) |
12(60%) |
|
xx |
9(10.3) |
1(2.3%) |
2(10%) |
|
ESR Pvu II |
|||
|
PP |
14(15.2%) |
4(8.9%) |
5(25%) |
|
Pp |
47(51.1%) |
27(60%) |
11(55%) |
|
pp |
31(33.7%) |
14(31.1%) |
4(20%) |
|
VDR Fok I |
|||
|
FF |
33(34.4%) |
15(33.3%) |
8(42.1%) |
|
Ff |
52(54.2%) |
20(44.4%) |
9(47.4%) |
|
ff |
11(11.5%) |
10(22.2%) |
2(10.5%) |
|
VDR Taq I |
|||
|
TT |
31(34.1%) |
18(41.9%) |
7(43.8%) |
|
Tt |
46(50.5%) |
20(46.5%) |
5(31.3%) |
|
tt |
14(15.4%) |
5(11.6%) |
4(25%) |
|
|
|||
|
Kapoor et al. Journal of Negative Results in BioMedicine 2007 6:7 doi:10.1186/1477-5751-6-7 |
|||